NCT01737892View on ClinicalTrials.gov

Assessment and Evaluation of Pharmacokinetic Profile of E004 in Healthy Adults

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Asthma
Interventions
DRUG

Arm T Epinephrine Inhalation Aerosol HFA, 125 mcg, 1 inhalation

Epinephrine Inhalation Aerosol HFA, Single dose 125 mcg, 1 inhalation

DRUG

Arm C-Epinephrine Inhalation Aerosol CFC

Epinephrine Inhalation Aerosol - CFC, Single dose 220 mcg, 1 inhalation

Trial Locations (1)

90630

West Coast Clinical Trials, LLC, Cypress

Sponsors
All Listed Sponsors
lead

Amphastar Pharmaceuticals, Inc.

INDUSTRY

NCT01737892 - Assessment and Evaluation of Pharmacokinetic Profile of E004 in Healthy Adults | Biotech Hunter | Biotech Hunter